🇨🇭SwissCham supports the consolidation of Mexico City as a Biopharmaceutical HUB
In a strategic meeting held on July 19, 2025, the Secretariat of Economic Development of Mexico City (SEDECO) of Mexico City, the Embassy of Switzerland Mexico and SwissCham Mexico joined efforts to attract investment in the biopharmaceutical and biotechnology sector.
🚀 With a global market valued at US$1.6 trillion and potential to reach US$8 trillion, Mexico could capture up to US$50 billion of that total. CDMX has exceptional talent in biotechnology, medicine and chemistry, as well as infrastructure, connectivity and a robust legal framework thanks to the treaty with Switzerland.
Learn more in the following article: